Literature DB >> 28174217

Diagnosis and Treatment of Hyponatremia: Compilation of the Guidelines.

Ewout J Hoorn1, Robert Zietse2.   

Abstract

Hyponatremia is a common water balance disorder that often poses a diagnostic or therapeutic challenge. Therefore, guidelines were developed by professional organizations, one from within the United States (2013) and one from within Europe (2014). This review discusses the diagnosis and treatment of hyponatremia, comparing the two guidelines and highlighting recent developments. Diagnostically, the initial step is to differentiate hypotonic from nonhypotonic hyponatremia. Hypotonic hyponatremia is further differentiated on the basis of urine osmolality, urine sodium level, and volume status. Recently identified parameters, including fractional uric acid excretion and plasma copeptin concentration, may further improve the diagnostic approach. The treatment for hyponatremia is chosen on the basis of duration and symptoms. For acute or severely symptomatic hyponatremia, both guidelines adopted the approach of giving a bolus of hypertonic saline. Although fluid restriction remains the first-line treatment for most forms of chronic hyponatremia, therapy to increase renal free water excretion is often necessary. Vasopressin receptor antagonists, urea, and loop diuretics serve this purpose, but received different recommendations in the two guidelines. Such discrepancies may relate to different interpretations of the limited evidence or differences in guideline methodology. Nevertheless, the development of guidelines has been important in advancing this evolving field.
Copyright © 2017 by the American Society of Nephrology.

Entities:  

Keywords:  cerebral edema; copeptin; osmotic demyelination syndrome; urea; vasopressin; vasopressin receptor antagonist

Mesh:

Substances:

Year:  2017        PMID: 28174217      PMCID: PMC5407738          DOI: 10.1681/ASN.2016101139

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  116 in total

Review 1.  Vasopressin receptor antagonists for the treatment of hyponatremia: systematic review and meta-analysis.

Authors:  Benaya Rozen-Zvi; Dafna Yahav; Mihai Gheorghiade; Asher Korzets; Leonard Leibovici; Uzi Gafter
Journal:  Am J Kidney Dis       Date:  2010-06-09       Impact factor: 8.860

2.  Efficacy and tolerance of urea compared with vaptans for long-term treatment of patients with SIADH.

Authors:  Alain Soupart; Michel Coffernils; Bruno Couturier; Fabrice Gankam-Kengne; Guy Decaux
Journal:  Clin J Am Soc Nephrol       Date:  2012-03-08       Impact factor: 8.237

3.  Treatment of Hyponatremic Encephalopathy.

Authors:  Aaron Spital
Journal:  Am J Kidney Dis       Date:  2015-09       Impact factor: 8.860

4.  Reference Change Values for Sodium Are Ignored by the American and European Treatment Guidelines for Hyponatremia.

Authors:  William P Tormey; Michael Carney; Martin Cuesta; Seamus Sreenan
Journal:  Clin Chem       Date:  2015-07-07       Impact factor: 8.327

Review 5.  Disorders of plasma sodium--causes, consequences, and correction.

Authors:  Richard H Sterns
Journal:  N Engl J Med       Date:  2015-01-01       Impact factor: 91.245

6.  Nephrogenic syndrome of inappropriate antidiuresis.

Authors:  Brian J Feldman; Stephen M Rosenthal; Gabriel A Vargas; Raymond G Fenwick; Eric A Huang; Mina Matsuda-Abedini; Robert H Lustig; Robert S Mathias; Anthony A Portale; Walter L Miller; Stephen E Gitelman
Journal:  N Engl J Med       Date:  2005-05-05       Impact factor: 91.245

7.  Osmotic demyelination syndrome following correction of hyponatremia.

Authors:  R H Sterns; J E Riggs; S S Schochet
Journal:  N Engl J Med       Date:  1986-06-12       Impact factor: 91.245

8.  Treatment of euvolemic hyponatremia in the intensive care unit by urea.

Authors:  Guy Decaux; Caroline Andres; Fabrice Gankam Kengne; Alain Soupart
Journal:  Crit Care       Date:  2010-10-14       Impact factor: 9.097

9.  Hyponatremia improvement is associated with a reduced risk of mortality: evidence from a meta-analysis.

Authors:  Giovanni Corona; Corinna Giuliani; Joseph G Verbalis; Gianni Forti; Mario Maggi; Alessandro Peri
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

10.  Application of a Mechanistic Model to Evaluate Putative Mechanisms of Tolvaptan Drug-Induced Liver Injury and Identify Patient Susceptibility Factors.

Authors:  Jeffrey L Woodhead; William J Brock; Sharin E Roth; Susan E Shoaf; Kim L R Brouwer; Rachel Church; Tom N Grammatopoulos; Linsey Stiles; Scott Q Siler; Brett A Howell; Merrie Mosedale; Paul B Watkins; Lisl K M Shoda
Journal:  Toxicol Sci       Date:  2016-09-21       Impact factor: 4.849

View more
  64 in total

Review 1.  Electrolyte and Acid-Base Disturbances in End-Stage Liver Disease: A Physiopathological Approach.

Authors:  José Víctor Jiménez; Diego Luis Carrillo-Pérez; Rodrigo Rosado-Canto; Ignacio García-Juárez; Aldo Torre; David Kershenobich; Eduardo Carrillo-Maravilla
Journal:  Dig Dis Sci       Date:  2017-05-13       Impact factor: 3.199

2.  Risk Factors and Outcomes of Rapid Correction of Severe Hyponatremia.

Authors:  Jason C George; Waleed Zafar; Ion Dan Bucaloiu; Alex R Chang
Journal:  Clin J Am Soc Nephrol       Date:  2018-06-05       Impact factor: 8.237

3.  Prognostic value of preoperative hyponatremia and thrombocytosis in patients with epithelial ovarian cancer.

Authors:  Katrin Hefler-Frischmuth; Christoph Grimm; Lisa Gensthaler; Elisabeth Reiser; Richard Schwameis; Lukas A Hefler
Journal:  Wien Klin Wochenschr       Date:  2018-09-03       Impact factor: 1.704

4.  "Pleurex Desalination" in Malignancy-related Ascites: A Novel Mechanism of Hyponatremia.

Authors:  Shruti Gupta; Gearoid M McMahon; Shveta S Motwani; David B Mount; Sushrut S Waikar
Journal:  Am J Clin Oncol       Date:  2020-01       Impact factor: 2.339

5.  [Symptomatic hyponatremia in a 43-year-old woman after a skiing accident with head injuries].

Authors:  M Kächele; R van Erp; K Schmid; L Bettac; M Wagner; B Schröppel
Journal:  Internist (Berl)       Date:  2020-01       Impact factor: 0.743

Review 6.  Evaluation of Hypervolemia in Children.

Authors:  Matjaž Kopač
Journal:  J Pediatr Intensive Care       Date:  2020-07-30

7.  Real-World, Non-Interventional, Retrospective Study (SAMPLE) of Tolvaptan in Patients with Hyponatraemia Secondary to the Syndrome of Inappropriate Antidiuretic Hormone Secretion.

Authors:  Antonio Pose-Reino; Isabelle Runkle de la Vega; Anne de Jong-Laird; Madhu Kabra; Uwe Lindner
Journal:  Adv Ther       Date:  2020-12-11       Impact factor: 3.845

8.  Evaluation of total LDH and its isoenzymes as markers in preeclampsia.

Authors:  Fazal Rimsha Saleem; Swetha Chandru; Monalisa Biswas
Journal:  J Med Biochem       Date:  2020-09-02       Impact factor: 3.402

Review 9.  Hyponatremia in Heart Failure: Pathogenesis and Management.

Authors:  Mario Rodriguez; Marcelo Hernandez; Wisit Cheungpasitporn; Kianoush B Kashani; Iqra Riaz; Janani Rangaswami; Eyal Herzog; Maya Guglin; Chayakrit Krittanawong
Journal:  Curr Cardiol Rev       Date:  2019

10.  Risk of Overcorrection in Rapid Intermittent Bolus vs Slow Continuous Infusion Therapies of Hypertonic Saline for Patients With Symptomatic Hyponatremia: The SALSA Randomized Clinical Trial.

Authors:  Seon Ha Baek; You Hwan Jo; Soyeon Ahn; Kristianne Medina-Liabres; Yun Kyu Oh; Jung Bok Lee; Sejoong Kim
Journal:  JAMA Intern Med       Date:  2021-01-01       Impact factor: 21.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.